[EN] HETEROARYL DIAMIDE IRE1/XBP1S ACTIVATORS<br/>[FR] HÉTÉROARYL-DIAMIDES ACTIVATEURS D'IRE1/XBP1S
申请人:PROTEGO BIOPHARMA INC
公开号:WO2022251533A1
公开(公告)日:2022-12-01
Provided herein are compounds that activate IRE1/XBP1s, and pharmaceutically acceptable derivatives thereof. Also provided are pharmaceutical compositions containing the compounds and methods of using the compounds for treating a subject having a disease or disorder that may be ameliorated by increasing IRE1/XBP1s activity.
本文提供了激活IRE1 / XBP1s的化合物及其药学上可接受的衍生物。还提供了含有这些化合物的制药组合物,并且提供了使用这些化合物治疗患有可能通过增加IRE1 / XBP1s活性而改善的疾病或障碍的方法。